Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Asset Utilization Ratio (2016 - 2025)

Haemonetics has reported Asset Utilization Ratio over the past 16 years, most recently at 0.53 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 1.62% year-over-year to 0.53; the TTM value through Dec 2025 reached 0.53, down 1.62%, while the annual FY2025 figure was 0.59, 7.59% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.53 at Haemonetics, down from 0.54 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.63 in Q3 2023 and troughed at 0.5 in Q3 2021.
  • A 5-year average of 0.56 and a median of 0.55 in 2021 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: fell 29.71% in 2021 and later rose 14.98% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.52 in 2021, then increased by 16.16% to 0.6 in 2022, then decreased by 0.03% to 0.6 in 2023, then dropped by 9.93% to 0.54 in 2024, then fell by 1.62% to 0.53 in 2025.
  • Business Quant data shows Asset Utilization Ratio for HAE at 0.53 in Q4 2025, 0.54 in Q3 2025, and 0.55 in Q2 2025.